Skip to main content

Berkeley Lights' Beacon Platform

Berkeley Lights has launched its Beacon platform, which accelerates cell line development and empowers immuno-oncology research. The new platform is powered by BLI's OptoSelect technology, which enables the precise movement, positioning, and interaction of cells on an opto-fluidic chip. Its automated workflows can shorten the typical development timeline by as much as three months, the company said. The platform also enables researchers to work at a single cell level with B-cells, multiple types of T-cells, myeloid cells, and other cells of interest.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.